Metropolis Healthcare Limited (METROPOLIS.NS)
- Previous Close
1,771.65 - Open
1,780.00 - Bid --
- Ask --
- Day's Range
1,773.10 - 1,819.95 - 52 Week Range
1,209.25 - 1,933.50 - Volume
210,126 - Avg. Volume
388,714 - Market Cap (intraday)
92.471B - Beta (5Y Monthly) 0.30
- PE Ratio (TTM)
74.37 - EPS (TTM)
24.27 - Earnings Date May 14, 2024 - May 18, 2024
- Forward Dividend & Yield 4.00 (0.23%)
- Ex-Dividend Date Nov 17, 2023
- 1y Target Est
2,781.58
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, and diagnosis of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.
www.metropolisindia.com4,300
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: METROPOLIS.NS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: METROPOLIS.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: METROPOLIS.NS
Valuation Measures
Market Cap
90.60B
Enterprise Value
91.76B
Trailing P/E
72.97
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.85
Price/Book (mrq)
8.67
Enterprise Value/Revenue
7.92
Enterprise Value/EBITDA
32.69
Financial Highlights
Profitability and Income Statement
Profit Margin
10.76%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
11.59B
Net Income Avi to Common (ttm)
1.25B
Diluted EPS (ttm)
24.27
Balance Sheet and Cash Flow
Total Cash (mrq)
1.07B
Total Debt/Equity (mrq)
22.02%
Levered Free Cash Flow (ttm)
--
Research Analysis: METROPOLIS.NS
Company Insights: METROPOLIS.NS
METROPOLIS.NS does not have Company Insights